Literature DB >> 15898128

Characterization of sialidase from bloodstream forms of Trypanosoma vivax.

L B Buratai1, A J Nok, S Ibrahim, I A Umar, K A N Esievo.   

Abstract

Sialidase (EC: 3.2.1.18) from Trypanosoma vivax (Agari Strain) was isolated from bloodstream forms of the parasite and purified to apparent electrophoretic homogeneity. The enzyme was purified 77-fold with a yield of 32% and co-eluted as a 66-kDa protein from a Sephadex G 110 column. The T. vivax sialidase was optimally active at 37 degrees C with an activation energy (E(a)) of 26.2 kJ mole(-1). The pH activity profile was broad with optimal activity at 6.5. The enzyme was activated by dithiothreitol and strongly inhibited by para-hydroxy mercuricbenzoate thus implicating a sulfhydryl group as a possible active site residue of the enzyme. Theenzyme hydrolysed Neu5Ac2,3lac and fetuin. It was inactive towards Neu5Ac2,6lac, colomic acid and the gangliosides GM1, and GDI. Initial velocity studies, for the determination of kinetic constants with fetuin as substrate gave a V(max) of 142.86 micromol h(-1) mg(-1) and a K(M) of 0.45 mM. The K(M) and V(max) with Neu5Ac-2,3lac were 0.17 mM and 840 micromole h(-1) mg(-1) respectively. The T. vivax sialidase was inhibited competitively by both 2,3 dideoxy neuraminic acid (Neu5Ac2,3en) and para-hydroxy oxamic acid. When ghost RBCs were used as substrates, the enzyme desialylated the RBCs from camel, goat, and zebu bull. The RBCs from dog, mouse and ndama bull were resistant to hydrolysis. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15898128     DOI: 10.1002/cbf.1189

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  7 in total

1.  Erythrocyte surface sialic acid levels of clinically healthy mongrel and exotic (alsatian and terrier) breeds of dogs.

Authors:  Nicodemus M Useh; Adenike I Aina; Abubakar A Adeiza; Andrew J Nok
Journal:  Glycoconj J       Date:  2007-05-16       Impact factor: 2.916

Review 2.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

3.  Production, purification and crystallization of a trans-sialidase from Trypanosoma vivax.

Authors:  Carole L F Haynes; Paul Ameloot; Han Remaut; Nico Callewaert; Yann G J Sterckx; Stefan Magez
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-21       Impact factor: 1.056

4.  β-Sitosterol could serve as a dual inhibitor of Trypanosoma congolense sialidase and phospholipase A2: in vitro kinetic analyses and molecular dynamic simulations.

Authors:  Suleiman Aminu; Ammar Usman Danazumi; Zainab Aliyu Alhafiz; Maria Wiktoria Gorna; Mohammed Auwal Ibrahim
Journal:  Mol Divers       Date:  2022-08-30       Impact factor: 3.364

5.  Trypanosoma vivax infections: pushing ahead with mouse models for the study of Nagana. I. Parasitological, hematological and pathological parameters.

Authors:  Nathalie Chamond; Alain Cosson; Marie Christine Blom-Potar; Grégory Jouvion; Simon D'Archivio; Mathieu Medina; Sabrina Droin-Bergère; Michel Huerre; Sophie Goyard; Paola Minoprio
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

6.  Identification of trans-sialidases as a common mediator of endothelial cell activation by African trypanosomes.

Authors:  Zeinab Ammar; Nicolas Plazolles; Théo Baltz; Virginie Coustou
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

7.  Phloroglucinol as a Potential Candidate against Trypanosoma congolense Infection: Insights from In Vivo, In Vitro, Molecular Docking and Molecular Dynamic Simulation Analyses.

Authors:  Nasirudeen Idowu Abdulrashid; Suleiman Aminu; Rahma Muhammad Adamu; Nasir Tajuddeen; Murtala Bindawa Isah; Isa Danladi Jatau; Abubakar Babando Aliyu; Mthokozisi Blessing Cedric Simelane; Elewechi Onyike; Mohammed Auwal Ibrahim
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.